Healthstream (HSTM) FY2013 results: revenue $132 million, up 27.5% on the year
Healthstream Inc. (HSTM) reported revenue of $132 million for fiscal 2013, the year ended 31 December 2013, up 27.5% on the year before. Net income was $8 million, up 10.1%, and diluted earnings per share $0.30. The figures are the company's own, from the 10-K it filed with the SEC on 4 March 2014.
Revenue
$132 million
+27.5% on the year
FY2009FY2013
Operating margin
11.1%
13.0% a year earlier
FY2009FY2013
Net income
$8 million
+10.1% on the year
FY2009FY2013
Diluted EPS
$0.30
+7.1% on the year
FY2009FY2013
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Revenue
132
104
82.1
+27.5%
Cost of revenue
n/a
41.7
31.1
Gross profit
n/a
62.1
51.0
Gross margin
n/a
59.8%
62.1%
Research and development
11.8
8.6
7.5
+36.6%
Operating income
14.7
13.5
11.3
+9.0%
Operating margin
11.1%
13.0%
13.8%
Pre-tax income
14.8
13.6
11.3
+9.3%
Income tax
6.4
5.9
4.4
+8.3%
Effective tax rate
43.3%
43.7%
38.8%
Net income
8.4
7.6
6.9
+10.1%
Net margin
6.4%
7.4%
8.5%
Diluted EPS
$0.30
$0.28
$0.29
+7.1%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Operating cash flow
26.3
22.5
19.8
+16.7%
Capital expenditure
4.4
4.3
4.1
+3.0%
Free cash flow
21.8
18.2
15.6
+20.0%
Free cash flow margin
16.5%
17.5%
19.1%
Cash from investing
-15.0
-59.0
-17.1
Cash from financing
6.9
0.9
56.4
+636.2%
Depreciation and amortisation
7.9
6.7
5.4
+17.9%
Share-based compensation
1.5
1.1
0.8
+28.3%
Diluted shares, weighted
28m
28m
24m
+0.6%
Shares outstanding at period end
27m
26m
26m
+4.2%
Balance sheet
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Shareholders' equity
149
132
121
+13.0%
Debt
0.0
0.0
0.0
Other liabilities
63.2
42.3
33.3
+49.2%
Total liabilities and equity
213
175
154
+21.8%
Fixed assets
9.0
7.8
6.1
+15.6%
Goodwill
35.7
29.3
21.1
+22.0%
Intangible assets
8.9
8.8
2.0
+0.7%
Investments
n/a
52.0
12.5
Cash and equivalents
59.5
41.4
76.9
+43.9%
Receivables
25.3
15.3
16.0
+64.9%
Other assets
74.1
19.9
19.6
+271.6%
Total assets
213
175
154
+21.8%
10-K for the year ended 31 December 2013, filed 4 March 2014: the filing.